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1I. INTRODUCTION/BACKGROUND
At the request of a concerned resident of Sandwich, Massachusetts, the Community Assessment
Program (CAP) of the Massachusetts Department of Public Health (MDPH), Center for
Environmental Health (CEH), reviewed the incidence of childhood cancer (i.e., ages 0-19) for
the town of Sandwich as a whole and in each of its four census tracts (CTs) (see Figure 1).
Specific concerns focused on a suspected increase in the incidence of cancer among children in
the town with particular concerns focused on more recent years.  Written correspondence to the
CEH from the Sandwich resident provided some information on 23 children from Sandwich
reported to have a diagnosis of cancer (some children were listed with an estimated year of
diagnosis but no other information; others had full names, addresses, cancer type, and diagnosis
dates).
The following review provides an evaluation of childhood cancer (all types) for all children
living in Sandwich who were diagnosed between 1995 – present to determine if childhood cancer
may be occurring in an unexpected pattern in the town of Sandwich as a whole or in any
particular area of the town.
II. METHODS FOR ANALYZING CANCER INCIDENCE
To investigate concerns about childhood cancer in Sandwich, the most recent data available from
the Massachusetts Cancer Registry (MCR) for Sandwich residents between the ages of 0 and 19
years were reviewed in an effort to confirm cancer diagnoses that were reported to the CEH,
identify any additional diagnoses, and to determine whether an atypical pattern of childhood
cancer may be occurring in the town as a whole or in any particular area of the town.  [Coding
for cancer types in this report follows the International Classification of Childhood Cancer
(ICCC) system.  See Appendix A for the incidence coding definitions used in this report.]
The MCR, a division within the MDPH Center for Health Information, Statistics, Research and
Evaluation, is a population-based surveillance system that has been monitoring cancer incidence
in the Commonwealth since 1982.  All new diagnoses of cancer among Massachusetts residents
2are required by law to be reported to the MCR within six months of the date of diagnosis
(M.G.L. c.111. s 111b).  This information is kept in a confidential database.  Data are collected
on a daily basis and are reviewed for accuracy and completeness on an annual basis.  This
process corrects misclassification of data (i.e., city/town misassignment) and deletes duplicate
case reports.  Once these steps are finished, the data for that year are considered “complete.”
Due to the volume of information received by the MCR, the large number of reporting facilities,
and the six-month period between diagnosis and required reporting, the most current registry
data that are complete will inherently be a minimum of two years prior to the current date.  At
the time of this analysis, complete data records available from the MCR include diagnoses that
occurred from 1/1/1982 – 12/31/2002.  Although the MCR data are currently complete through
2002, this is an on-going surveillance system that collects reports on a daily basis.  Therefore, it
is possible to review case reports for more recent years (i.e., 2003-present), which can provide a
qualitative review of cancer patterns in a given area.1  To determine whether there may be
additional recent diagnoses not yet reported to the MCR, staff from the MCR contacted the five
medical centers in Massachusetts that routinely treat pediatric oncology patients (i.e., Dana
Farber/Children’s Hospital, Massachusetts General Hospital, New England Medical Center,
University of Massachusetts Medical Center, and Baystate Medical Center) and requested the
registrars to review hospital databases for any records of pediatric cancer patients residing in
Sandwich.  In addition, MCR staff contacted the central registry in Rhode Island in an effort to
identify patients who may have traveled to Rhode Island for treatment.
It is important to note that although some non-cancerous (i.e., benign) tumors are reported to the
MCR (e.g., those diagnosed in the brain and central nervous system), these cases are not
included in the data summarized here.  Also, only primary site (original location in the body)
cancers are included in the MCR.  Cancers that occur as the result of a primary site cancer
spreading to another location in the body (i.e., metastasis) are not considered separate cancers.
Therefore, this analysis includes only diagnoses of invasive (i.e., malignant) primary cancers.
1 The data summarized here are drawn from data entered on MCR computer files before December 31, 2005.  The
numbers presented may differ slightly from those published in previous or future reports, reflecting late reported
cases, address corrections, or other changes based on subsequent details from reporting facilities.
3In order to determine whether cancer incidence in a community is occurring at a higher or lower
rate than expected, a statistic called the standardized incidence ratio (SIR) is calculated using
data from the MCR.  More specifically, an SIR is the number of observed cancer cases in a town
divided by the number of expected cases based on the population of the town and the state’s
cancer rates.2  An SIR greater than 100 indicates that more cancer cases occurred than expected;
an SIR less than 100 means that fewer cases occurred than expected.  For example, an SIR of
150 is interpreted as 50 percent more cases than expected; an SIR of 90 indicates 10 percent
fewer cases than expected.  When an SIR is statistically significant, as indicated by an asterisk
symbol (*), there is less than a 5% chance that the observed number of cases is due to chance
alone.  SIRs and 95% confidence intervals (CIs), statistics used to help interpret the SIR, are not
calculated when the observed number of cases is fewer than five.  A more detailed explanation of
SIRs and 95% CIs is provided in Appendix B.
SIRs for childhood cancer (all types) for the town of Sandwich as a whole as well as for each CT
within Sandwich were calculated for the 8-year time period 1995 – 2002.  Because statewide
data for the years 2003 – present are not considered complete, expected numbers of diagnoses
and incidence ratios cannot be calculated for this more recent time period.
Accurate age group and gender-specific population data are required to calculate SIRs.
Therefore, the CT is the smallest geographic area for which cancer rates can be accurately
calculated.  Specifically, a CT is a smaller statistical subdivision of a county as defined by the
U.S. Census Bureau.  CTs usually contain between 2,500 and 8,000 persons and are designed to
be homogeneous with respect to population characteristics (U.S. DOC, 1990).  As stated above,
an SIR and 95% CIs are not calculated when the observed number of cases is fewer than five.
To better characterize the pattern of childhood cancer incidence in Sandwich, case-specific
information available from the MCR relating to type of cancer, date of diagnosis, age at
diagnosis, and gender was also reviewed for each child diagnosed with cancer in Sandwich.  This
information is discussed in the context of known or established cancer risk factors and incidence
2 Using different population estimates or statistical methodologies, such as grouping ages differently or rounding off
numbers at different points during calculations, may produce results slightly different from those published here.
4patterns in the general population.  In addition, place of residence at the time of diagnosis for
each individual between the ages of 0 and 19 with cancer was “mapped” [using a computerized
geographic information system (ESRI, 2005)].  This allowed for a qualitative evaluation of the
spatial distribution of the addresses of children diagnosed with cancer and an assessment of any
possible geographic concentration of diagnoses in specific neighborhoods in Sandwich.  For
confidentiality reasons, maps of the residences of individuals diagnosed with cancer cannot be
provided in this report.  However, a summary of this evaluation with any notable findings is
presented in this report.
III. RESULTS OF CHILDHOOD CANCER INCIDENCE ANALYSES
A. Efforts to Confirm Reported Cases
As stated earlier, information on 23 children from Sandwich reported to have a diagnosis of
cancer was provided to the CEH by a concerned resident of Sandwich.  Name, cancer type, age
at diagnosis, and/or address was provided for 20 of the 23 children.  The year of diagnosis was
the only information reported to the CEH for the other three children.
From 1995 – 2002 (the most recent time period for which complete data is available from the
MCR), 10 children from Sandwich were reported to the MCR with a diagnosis of cancer.  From
January 2003 through December 2005, the MCR has received reports of seven children in
Sandwich diagnosed with cancer.  Staff from the MCR also contacted the five medical centers in
Massachusetts that routinely treat pediatric oncology patients and the central cancer registry in
Rhode Island to look for any additional children in Sandwich recently diagnosed but not yet
reported to the MCR.  As of January 23, 2006, no additional children from Sandwich were
identified as being treated for cancer.  Therefore, seven children have been reported to the MCR
from 2003 through 2005.
Of the 23 children reported to the CEH by the Sandwich resident, the CAP was able to confirm
14 diagnoses using the MCR and a search of hospital databases.  In some instances, case-specific
information confirmed via the MCR (e.g., cancer type, age at diagnosis, year of diagnosis) was
different from that reported to the CEH.  Of the nine children whose diagnosis was not
5confirmed, one individual was confirmed by the MCR as being diagnosed with cancer after the
age of 19, i.e., not a childhood cancer.  A second child was confirmed in the MCR as being
diagnosed with cancer, however, this child was not a resident of Sandwich at the time of
diagnosis.  The remaining seven reports could not be confirmed, in part because of insufficient
information (e.g., name and address were not provided for three of these seven children).  It is
important to note that a year of diagnosis was provided for six of these seven individuals.  All six
individuals were reported as being diagnosed between 2001 and 2004.  Because MCR staff
contacted hospitals in MA and the RI cancer registry for reports of more recent diagnoses, it is
unlikely these individuals would have been excluded if they had been diagnosed with cancer in
the town of Sandwich.  However, searches of hospital databases were based on reported address
at the time of diagnosis.  Children whose parent or guardian reported an address other than
Sandwich would not have been identified.  For these reasons such individuals would not be
included in the MCR data files for Sandwich.  Finally, it is also possible that some of these
individuals may have actually been diagnosed with a benign tumor or other pre-cancerous (e.g.,
aplastic anemia) or non-cancerous conditions.
B. Childhood Cancer Incidence in Sandwich, 1995-2002
1. Town-wide
Table 1 summarizes childhood cancer incidence data for the town of Sandwich for the 8-year
time period 1995 – 2002.  Overall, cancer occurred more often than expected among children
aged 0-19 years in Sandwich during this time period (10 diagnoses observed vs. 7.5 expected,
SIR = 133).  This elevation was not statistically significant (95% CI = 64-245).  A separate
evaluation of these data by gender revealed that the incidence among males was slightly less than
expected, while female children were diagnosed more often than expected in the town.
Specifically, three males in Sandwich were diagnosed with cancer during this time period
compared to four children that would have been expected to have a diagnosis of cancer.  As
explained previously, an SIR and 95% CI were not calculated for males due to the small number
of observed diagnoses (i.e., less than five).  Among females in the town, seven diagnoses were
6observed compared to 3.5 expected (SIR = 200).  This elevation did not achieve statistical
significance (95% CI = 80-412).
Table 1: Childhood cancer incidence in Sandwich, MA: 1995-2002
Observed Expected SIR 95% CI
Males 3 4.0 NC NC
Females 7 3.5 200 80-412
Total 10 7.5 133 64-245
Notes: 95% CI = 95% confidence interval; NC = not calculated; * = statistical significance
The cancer types diagnosed among these 10 children during 1995 – 2002 included leukemia (n =
3), Central Nervous System and Miscellaneous Intracranial and Intraspinal Neoplasms [CNS
tumors (n = 3)], cancer of the bone (n = 1), soft tissue sarcoma (n = 2), and Hodgkin’s disease (n
= 1).  These cancers are among the most common cancer types diagnosed among children (i.e.,
ages 0-19).  The number of diagnoses per year varied between zero and two with at least one
diagnosis occurring in seven of the eight years.
2. Census Tracts
The incidence of childhood cancer for each of the four census tracts in Sandwich is summarized
in Table 2.  Among males and females combined, childhood cancer incidence was close to the
number of expected cases in three of the four CTs.  In CT 0135, located in southeast Sandwich, 5
children were diagnosed with cancer while approximately three were expected (SIR = 192); this
elevation was not statistically significant (95% CI = 62-449).  The overall elevation was due to
an elevation among female children in this CT (4 observed vs. 1.2 expected).
The cancer types diagnosed among the four females in CT 0135 included two diagnoses of
leukemia (both lymphoid leukemia), a cancer of the bone, and a soft tissue sarcoma.  Three of
these four females lived within a half mile of each other and their diagnoses occurred from 1996
to 1999.  It is important to note that this area of Sandwich is among the more densely populated
7areas of town.  Other than CT 0135, childhood cancer diagnoses during this time period were
evenly distributed throughout the town.
Table 2: Childhood cancer incidence in Sandwich Census Tracts: 1995-2002
Total Males FemalesCensus Tract
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI
0133 1 0.9 NC NC-NC 0 0.4 NC NC-NC 1 0.4 NC NC-NC
0134 2 1.3 NC NC-NC 1 0.7 NC NC-NC 1 0.6 NC NC-NC
0135 5 2.6 192 62-449 1 1.4 NC NC-NC 4 1.2 NC NC-NC
0136 2 2.7 NC NC-NC 1 1.4 NC NC-NC 1 1.2 NC NC-NC
Town Total 10 7.5 133 64-245 3 4.0 NC NC-NC 7 3.5 200 80-412
Notes: Obs = observed; Exp = expected; 95% CI = 95% confidence interval;
NC = not calculated
3. Incidence in Sandwich by Cancer Type
a. Leukemias
Leukemia is a group of cancers that develop in the blood-forming tissues (MDPH, 2003).
Leukemia and CNS tumors were the most common cancer types diagnosed among children in
Sandwich during 1995 – 2002.  Of the 10 children diagnosed with cancer during this time period,
three (30%) were diagnosed with leukemia.  Two children were diagnosed in 1999 and one child
was diagnosed in 2001.
In children, leukemia is classified into four major subtypes: lymphoid leukemia, acute myeloid
leukemia (AML), chronic myelodysplastic disease, and myelodysplastic syndrome.  In
Massachusetts, the majority of childhood leukemia diagnoses are of the lymphoid leukemia
subtype (MDPH, 2003).  During 1995 – 2002, all three childhood leukemia diagnoses observed
were lymphoid leukemias.  According to the American Cancer Society (ACS), lymphoid
leukemia is most commonly diagnosed among children 2 – 3 years old (ACS, 2005a).  Two of
the three children fit the pattern suggested by the ACS and the third child was between the ages
of five and 10 years old at diagnosis.
8b. Central Nervous System and Miscellaneous Intracranial and Intraspinal
Neoplasms
Central Nervous System and Miscellaneous Intracranial and Intraspinal Neoplasms (CNS
tumors) include tumors that arise from the brain, spinal cord, and other sites within the skull and
spinal cord (MDPH, 2003).  Statewide, these tumors are the second most common type of cancer
in children.  In Sandwich, three (30%) children were diagnosed with a CNS tumor from 1995 –
2002 over a period of five years (beginning in 1997).
There are several different types of CNS tumors, including astrocytomas, ependymomas,
primitive neuroectodermal tumors (PNET) and medulloblastomas, as well as some rare types.  In
Sandwich, one child was diagnosed with an astrocytoma, one was diagnosed with an
ependymoma, and one was diagnosed with a PNET during 1995 – 2002.  According to the
American Brain Tumor Association (ABTA), CNS tumors typically affect children under fifteen
years of age and older adults (ABTA, 2005).  Of the three children diagnosed with neoplasms of
the CNS, all were diagnosed at ages younger than 15.
c. Soft-tissue Sarcomas
Soft-tissue sarcomas are cancers that develop in the supporting tissues, such as muscle, fat and
blood vessels (MDPH, 2003).  These cancers can develop at any site in the body.  In
Massachusetts, soft tissue sarcomas represent about 7.4% of all childhood cancer diagnoses
(MDPH, 2003), similar to national trends (CDC, 2003).  The most common type of childhood
soft tissue sarcoma is rhabdomyosarcoma, which develops in skeletal muscle (ACS, 2005b).
There are many different types of soft tissue sarcomas, which are all thought to be medically
related to each other.  In Sandwich, two children were diagnosed with a soft tissue sarcoma
during 1995 – 2002.  The diagnoses for these two children occurred over a 14-month period
beginning in 1996.  One child was diagnosed with a rhabdomyosarcoma and one was diagnosed
with a less common type of soft tissue sarcoma found in cartilage and bone.
According to the Centers for Disease Control and Prevention (CDC), soft tissue sarcomas are
most commonly diagnosed in children less than one year old and in children aged 15 – 19 (CDC,
92003).  During 1995 – 2002, the incidence in Sandwich was consistent with this trend; one
individual was diagnosed at less than one year old and the other was over 15 years of age at the
time of diagnosis.
d. Malignant Bone Tumors
In Massachusetts, malignant bone cancers account for about 5% of all childhood cancers
(MDPH, 2003).  In Sandwich, one child was diagnosed with bone cancer from 1995 – 2002.
This child’s cancer was in the Ewing’s family of tumors.  Ewing’s tumors are most often found
in bone but can also develop in soft tissues.  According to the American Cancer Society, only
about 250 children and adolescents are diagnosed with Ewing’s tumors (in either the bone or soft
tissues) in the U.S. each year, accounting for less than three percent of all childhood cancers
(ACS, 2005c).  Ewing’s tumors comprise about 27% of malignant bone tumors diagnosed in
children in Massachusetts (MDPH, 2003).  The majority occur in individuals aged 10 to 20, but
Ewing’s tumors can also affect children under 10 and young adults into their twenties (Gurney et
al., 1999).  The child diagnosed with bone cancer was diagnosed before age 10.
e. Lymphomas and Reticuloendothelial Neoplasms
Lymphomas are cancers that develop from the lymphatic or reticuloendothelial (lymphocyte
supporting tissue) system, the system of the body that helps fight infection and disease (MDPH,
2003). There are two main types of lymphomas: Hodgkin’s disease and non-Hodgkin’s
lymphoma (NHL).  Although the overall incidence of each type is similar in children aged 0-19,
NHL tends to occur more often in younger children, while Hodgkin’s disease is more common in
adolescents (ACS, 2005d).  Of the 10 children diagnosed with cancer in Sandwich during 1995 –
2002, one was diagnosed with Hodgkin’s disease as an adolescent (between the ages of 15-19).
There were no diagnoses of NHL among children in Sandwich reported to the MCR during the
time period evaluated.
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C. Childhood Cancer Incidence, 2003 – 2005
As stated earlier, because statewide data for the years 2003 – present cannot be considered
complete, expected numbers of diagnoses and incidence ratios cannot be calculated for more
recent years.  However, this section provides a qualitative review of childhood cancer in
Sandwich for more recent years (i.e., 2003 – present).
From January 2003 to December 2005, seven children (four females and three males) reported to
the MCR as residents of Sandwich were diagnosed with cancer.  The cancer types diagnosed
among these children were leukemia (n = 3), CNS tumors (n = 2) and cancer of the bone (n = 2).
Of the seven diagnoses that were reported for the years 2003 – present, three occurred during
2003, one in 2004, and three in 2005.
Among the seven children reported to the MCR during 2003 – 2005, two resided in CT 0133,
two were in CT 0134, and three resided in CT 0135 at the time of diagnosis.  At the time of this
report, no children from Sandwich CT 0136 had been reported to the MCR with a diagnosis of
cancer from 2003 through 2005.  The two children living in CT 0133 were both diagnosed with
tumors of the CNS.  Both of the individuals residing in CT 0134 were diagnosed with leukemia,
and of the three children living in CT 0135, one was diagnosed with leukemia and the other two
were diagnosed with bone cancer.
Of note, the child diagnosed with leukemia in CT 0135 was living in the same neighborhood of
southeast Sandwich at diagnosis where three other children diagnosed with cancer during 1995 –
2002 were living.  Therefore, during the nine-year time period between 1996 and 2005, four
children (3 with leukemia and 1 soft tissue sarcoma) were diagnosed with cancer in this area of
Sandwich.  In addition, in a different neighborhood of CT 0135, one of the children diagnosed
with bone cancer during 2003 – 2005 was living in close proximity to another child diagnosed
with bone cancer during 1995 – 2002.  Although these children were diagnosed with similar
types of bone cancer (i.e., Ewing’s family of tumors), they were different ages at the time of
diagnosis and were diagnosed about five years apart from each other.  The other child diagnosed
11
with bone cancer in Sandwich during 2003 – 2005 was a resident of CT 0135 but was living
approximately two and one-half miles away from these two children at the time of diagnosis.
1. Incidence by Cancer Type
a. Leukemias
Leukemia was the most common type of cancer (43%) diagnosed among children in Sandwich
during 2003 – 2005.  Of the three children diagnosed with leukemia during this time period, two
were diagnosed before age 10 and the third was over age ten at the time of diagnosis.  All three
children were diagnosed with lymphoid leukemia.
b. Central Nervous System and Miscellaneous Intracranial and Intraspinal
Neoplasms
Two children were diagnosed with a CNS tumor during 2003 – 2005.  One child was between
the ages of five and ten at diagnosis while the second child was between 10 and 14 years old at
the time of diagnosis.  Each child was diagnosed with a different type of tumor of the CNS.  One
child was diagnosed with a PNET (diagnosed in 2003) and the other was diagnosed with a
medulloblastoma (diagnosed in 2005).
c. Malignant Bone Tumors
Two of the seven children were diagnosed with bone cancer; both were classified in the Ewing’s
family of tumors.  One child (diagnosed in 2005) was between 10 and 15 years of age at the time
of diagnosis, and the other child (diagnosed in 2003) was over the age of 15 at diagnosis.
D. Residential History
In general, many adult cancers have latency periods (i.e., the interval between first exposure to a
disease-causing agent and the appearance of symptoms of the disease [Last, 1995]) that can
range from 10 to 30 years and in some cases may be more than 40 or 50 years (Bang, 1996;
Frumkin, 1995).  While not much is known about the latency period for cancers that occur in
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children (other than latency is assumed to be considerably shorter), the length of time in which
an individual lived in a specific area may help determine the importance that their place of
residence might have in terms of exposure to a potential environmental source.  Therefore, a
residential history of each child diagnosed with cancer in Sandwich was constructed, with
particular attention paid to the children mentioned earlier in this report who are living in close
proximity to each other in two different areas of CT 0135 in Sandwich.
Residential histories were constructed by consulting Massachusetts birth records from the
Registry of Vital Records and Statistics and the Town of Sandwich annual street listings.  For 16
of the 17 children, length of residence at the address reported at diagnosis was determined.
Review of this information indicated that six children had lived at their reported address since
birth.  Ten children were not born at the same residence reported to the MCR as their residence
at diagnosis.  These families moved to the MCR-reported address between one and eleven years
after birth.  Length of residence at the address reported at diagnosis varied between two to fifteen
years.
With respect to the one area of Sandwich where four children were diagnosed with cancer since
1996, two individuals were born at the address reported to the MCR at the time of diagnosis.
Both of these children were diagnosed with leukemia, however, their diagnoses were
approximately six years apart.  The remaining two children were not born at the address reported
to the MCR at diagnosis.  One child, diagnosed with leukemia lived at this address less than
three years before diagnosis.  The other child, diagnosed with a soft tissue sarcoma, lived at their
address between five and seven years before diagnosis.
In regard to the other area of Sandwich where two children with bone cancer were living, neither
of these two children was born at the address reported to the MCR at diagnosis.  Both of these
children lived at their residence at diagnosis in Sandwich between five and 10 years before being
diagnosed with bone cancer.  As stated earlier, the diagnoses of these children occurred
approximately five years apart.
13
IV. ENVIRONMENTAL FACTORS
In addition to reviewing the pattern of cancer incidence among children in Sandwich, available
information regarding Sandwich drinking water, and data for any groundwater contamination
from the Massachusetts Military Reservation (MMR) was also reviewed.
A. Sandwich Municipal Drinking Water
Under the Federal Safe Drinking Water Act, all public water suppliers nationwide are required
by the U.S. Environmental Protection Agency (EPA) to test for a wide variety of substances.
The Massachusetts Department of Environmental Protection (MDEP) requires local water
suppliers to perform over 100 tests for the presence of different organic and inorganic
contaminants.  The MDEP has also established Massachusetts’ Maximum Contaminant Levels
(MMCLs) which are regulatory limits for contaminants in public drinking water supplies.
According to information collected by the 1990 US Census, the percentages of households using
public drinking water varied for each of Sandwich’s four CTs.  Most or all households in CTs
0133 and 0136 (See Figure 1) were reportedly using municipal drinking water in 1990 (100% in
CT 0133 and 90% in CT 0136).  Approximately half (55%) of households in CT 0134 were
supplied by public drinking water, while 36% of household in CT 0135 were using public
drinking water.  The number of households served by public drinking water was not collected in
the 2000 Census.
MDEP provided information on any violations of drinking water standards for the Sandwich
municipal drinking water system during the period 1993 to present.  With the exception of total
coliform (TC), no violations of health-based drinking water standards have been reported for the
Sandwich drinking water supply during this time period.  From 1995 to 1997 four instances have
occurred in Sandwich where the MCL for TC has been exceeded.  Total coliforms are a group of
related bacteria that are generally harmless, are common in the environment, and serve as an
indicator of the presence of other potentially harmful bacteria (EPA, 2001; MDEP, 2005).
According to the MDEP, follow-up sampling as required did not indicate the presence of harmful
bacteria (Thompson, 2005).
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B. Groundwater Contamination from MMR
To date, a total of 14 groundwater contaminant plumes from various areas of the MMR have
been identified in Bourne, Sandwich, Mashpee, and Falmouth (AFCEE, 2005).  A plume is a
body of groundwater containing contaminants exceeding the state and/or federal MCLs based on
sampling from various locations.  Review of the location of these plumes indicated that no
children diagnosed with cancer in Sandwich were living near any of these plumes.
V. DISCUSSION
Although most cancer types occur more frequently in older populations (i.e., age 50 and over),
cancer can affect people of all ages.  When evaluating cancer patterns in adults, different cancers
are treated as different diseases, each with different causes and risk factors.  However, some
childhood cancers may have similar etiologies and are often grouped together to reflect
similarities in histology or cell type [e.g., leukemias, lymphomas (including Hodgkin’s disease
and NHL), tumors of the central nervous system, and soft tissue sarcomas] (Birch and Marsden,
1987; MDPH, 2003).  Unfortunately, very little is known about the etiology of childhood cancer.
In addition, some of the risk factors for childhood cancers may differ from the risk factors for
adult cancers.
Between 1995 and 2002, 2182 Massachusetts children between the ages of 0 and 19 were
diagnosed with cancer.  Leukemia is the most common type of childhood cancer in
Massachusetts children aged 0 to 19 years, followed by cancers of the CNS.  Other common
childhood cancers include non-Hodgkin’s lymphoma (NHL), Hodgkin’s disease, soft tissue
sarcoma, Wilms’ tumor (a type of kidney cancer), neuroblastoma, and some bone cancers.  For
the most part, the distribution of cancer types diagnosed among children in Sandwich during
1995 – 2005 was consistent with state and national trends.  Specific information on each of the
five cancer types diagnosed among children in Sandwich is discussed below.  Appendix C of this
report provides more information regarding risk factors for the types of cancer diagnosed among
children in Sandwich.
15
Three children from Sandwich were reported to the MCR with leukemia during the eight year
time period 1995 – 2002.  Since 2003, three other children from Sandwich have been reported to
the MCR with leukemia.  While it appears that the incidence of this cancer type is increasing
among children in Sandwich, this is consistent with a slight rise in leukemia incidence among
children both statewide and across the country (MDPH, 2003; Ries et al., 2005).  A few risk
factors for the development of childhood leukemia have been identified.  Some children with
certain genetic diseases (e.g., Down’s syndrome and Klinefelter’s syndrome) have an increased
risk of developing this cancer (Chow et al., 1996; ACS, 2005a).  An MDPH study published in
2002 showed that maternal exposure to drinking water contaminated with solvents and metals
during pregnancy was likely associated with their children’s development of leukemia (Costas et
al., 2002).  While Sandwich drinking water was not found to contain these contaminants above
MDEP guidelines, information from the 1990 US Census indicates that only 36% of households
in CT 0135 were on public water.  In addition, high-dose radiation exposure, including prenatal
exposure to x-rays, has been associated with an increased risk of leukemia in children (Chow et
al., 1996; ACS, 2005a).  As noted in this report, three of the six children diagnosed with
leukemia were living in a neighborhood of southeast Sandwich (in CT 0135) at the time of
diagnosis.  These three children were diagnosed with leukemia over a 6-year period.  Two of the
three children were born at the address reported to the MCR at diagnosis.  The remaining child
was not born at the same address as he/she was living at diagnosis; this child had lived at his/her
residence at diagnosis two years before being diagnosed with leukemia.
During 1995 – 2005, four different subtypes of CNS tumors commonly found in children were
diagnosed among five children in Sandwich.  Some causes of CNS tumors in children have been
identified.  The only known environmental risk factor for CNS tumors is treatment with ionizing
radiation (e.g., from radiation therapy to the head and neck) (ACS, 2005e; Chow et al., 1996).  In
addition, rare cases of CNS tumors run in some families.  Some types have also been associated
with certain rare genetic disorders, such as neurofibromatosis type 1, von Hippel-Lindau disease,
and Li-Fraumeni syndrome (ACS, 2005e; Chow et al., 1996).  Environmental exposures, such as
vinyl chloride, aspartame (a sugar substitute), and electromagnetic fields, have been suggested as
risk factors for brain cancer, but the evidence to support these associations is inconsistent (ACS,
2005e).  Two of the five children diagnosed with CNS tumors were born at the address listed at
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diagnosis.  Of the remaining three children, two were not born at the address they were living at
when diagnosed.  These two children had been at their address between zero and two years
before diagnosis.  A residential history for the fifth child from Sandwich diagnosed with a CNS
tumor could not be confirmed.  Therefore, it is likely this child’s family only lived at this address
for a short time (e.g., less than one year) prior to diagnosis.
In general, the causes of bone cancer are unknown.  However, a small number of children with
certain rare inherited syndromes (e.g., Li-Fraumeni syndrome and Rothmund-Thompson
syndrome) or certain non-cancerous bone diseases (e.g., Paget’s disease) may be at an increased
risk of developing some types of bone cancer.  Also, exposure to large doses of ionizing
radiation (e.g., radiation therapy to treat another cancer) poses an increased risk of developing
bone cancer (ACS, 2005f).  There are no known risk factors for Ewing’s tumors.  Moreover,
studies of children with Ewing’s tumors have not linked this cancer to radiation, chemicals, or
any other environmental exposures (ACS, 2005c).  The three children diagnosed with bone
cancer in Sandwich were diagnosed with a Ewing’s related tumor.  While two of the three
children diagnosed with bone cancer were living in the same neighborhood in the southern part
of town, their diagnoses were 5 years apart.  Neither of these two children were born at the
address at diagnosis reported in the MCR, but they had been at their address at diagnosis in
Sandwich between five and 10 years before being diagnosed with bone cancer.  The third child,
diagnosed with bone cancer in 2005, was living in a neighborhood approximately two and one-
half miles from the other two children at diagnosis.
Since the second of two children in Sandwich was diagnosed with a soft tissue sarcoma in 1997,
no other Sandwich children have been reported to the MCR with this type of cancer.  No pattern
with respect to residence at diagnosis emerged when reviewing the residential history and
geographic distribution for each child diagnosed with a soft tissue sarcoma.  The family of one
child had been at the residence at diagnosis less than a year between the date of birth and the date
of diagnosis.  The second child was not born at the address listed in the MCR and had been
living at this address for approximately 6 years before being diagnosed with soft tissue sarcoma.
The places of residence at diagnosis for these two children were approximately four and one-half
miles apart from one another, and in different CTs.  Some causes of soft tissue sarcoma among
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children have been identified.  Certain inherited conditions (e.g., neurofibromatosis, Gardner’s
syndrome, and Li-Fraumeni syndrome) are associated with an increased risk of soft tissue
sarcoma (ACS, 2005g; Chow et al., 1996).  In addition, exposure to ionizing radiation (e.g., for
the treatment of other cancers) is a risk factor for soft tissue sarcoma (Zham et al., 1996).  The
average time between radiation exposure and diagnosis of a sarcoma in adults is approximately
10 years (ACS, 2005g).  However, it is estimated that this risk factor accounts for less than five
percent of all diagnoses.  Some studies have suggested possible links between soft tissue
sarcoma and occupational exposure to high doses of certain pesticides (ACS, 2005g).  Pesticide
exposure has also been associated with childhood rhabdomyosarcoma (Chow et al., 1996).
Hodgkin’s disease has been associated with immune deficiencies (Mueller, 1996; Scherr and
Mueller, 1996).  While environmental factors have been considered in some epidemiological
studies, they are not thought to be strongly associated with Hodgkin’s disease.  An increased risk
of Hodgkin’s disease has been associated with Epstein-Barr virus (EBV) infection (the virus that
causes infectious mononucleosis) (Mueller, 1996).  Although the disease is relatively rare among
children, two peaks in the age distribution have been observed for this cancer type.  The first
peak occurs in young adults usually between the ages of 15 to 40 (typically ages 25-30) and the
second peak occurs in adults aged 55 years and above.  The child diagnosed with Hodgkin’s
disease in Sandwich was between the ages of 15 and 19 at diagnosis which is consistent with
patterns observed for this cancer type.  Occupational exposures to workers in the chemical
industry and woodworkers have also been suggested in several epidemiologic studies to be
associated with the development of Hodgkin’s disease.  However, specific chemical exposures
related to the development of this disease have not been identified and results of studies
investigating occupational exposures are inconsistent (Mueller, 1996).  Although specific genetic
factors have not been identified, some studies of twins with Hodgkin’s disease have suggested
that family history may play a role in the development of this disease among some individuals
(ACS, 2005d; Percy et al., 1999).
According to statistics from the American Cancer Society, cancer is the second leading cause of
death in Massachusetts and the United States.  Not only will one out of three people develop
cancer in their lifetime, but also this disease will affect three out of every four families.  For this
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reason, cancers often appear to occur in “clusters,” and it is understandable that someone may
perceive that there are an unusually high number of cancer cases in their surrounding
neighborhood or town.  Upon close examination, many of these “clusters” are not unusual
increases, as first thought, but are related to such factors as local population density, variations in
reporting or chance fluctuations in occurrence.  In other instances, the “cluster” in question
includes a high concentration of individuals who possess related behaviors or risk factors for
cancer.  Some, however, are unusual; that is, they represent a true excess of cancer in a
workplace, a community, or among a subgroup of people.  A suspected cluster is more likely to
be a true cancer cluster if it involves a large number of cases of one type of cancer diagnosed in a
relatively short time period rather than several different types diagnosed over a long period of
time (i.e., 20 years), a rare type of cancer rather than common types, and a large number of cases
diagnosed among individuals in age groups not usually affected by that cancer.  These types of
clusters may warrant further public health investigation.
In general, the geographic distribution of children diagnosed with cancer closely matched the
pattern of population density in Sandwich.  However, an atypical geographic pattern in SE
Sandwich was observed during this time period.
VI. CONCLUSIONS
· For the eight-year period of 1995 through 2002, the incidence of childhood cancer in
Sandwich was slightly elevated (10 diagnoses observed versus 7.5 diagnoses expected),
but this elevation was not statistically significant.  The elevation was due primarily to an
elevation among female children in CT 0135 (4 diagnoses observed versus 1.2 diagnoses
expected);
· Within CT 0135, four females were diagnosed with cancer between 1996 and 1999.
Among these four children, two were diagnosed with leukemia, and there was one
diagnosis of bone cancer, and a soft tissue sarcoma;
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· For the three-year period of 2003 through 2005, the period for which an expected number
of diagnoses cannot yet be calculated using statewide incidence rates, seven children in
Sandwich were reported to the MCR with a diagnosis of three different types of cancer;
· When age at diagnosis and cancer type was examined for each child in Sandwich
diagnosed with cancer from 1995 – 2005, the distribution of both variables was consistent
with the epidemiologic literature for the types of cancer reported;
· When the timing and geographic distribution of childhood cancer in Sandwich was
examined, two observations were noted:
o One observation involved two children with the same type of cancer, bone cancer,
living in fairly close proximity to one another in southern Sandwich.  Although
geographically close, they were diagnosed approximately five years apart;
o The second observation involved four children living in close proximity (within a
half-mile radius) to each other in southeastern Sandwich.  Three of the four
children were diagnosed with leukemia and the fourth child was diagnosed with a
soft tissue sarcoma.  Two of the three children with leukemia were diagnosed
within five months of one another.  The residential history of these three children
revealed that two of the children resided in their homes for approximately 3 to 3.5
years before diagnosis, the same homes that they were born in.  The other child
had moved from the home that he/she was born in and lived in their residence at
diagnosis for two years.  Because of the uncertainties about the roles of latency
periods and potential exposures during pregnancy for childhood cancer, and the
small number of cases, it is difficult to assess how unusual this pattern may be.
· The distribution of childhood cancer did not appear to correspond to areas of Sandwich
where there might be greater opportunities for exposure to MMR groundwater plumes.
In addition, since 1993, no violations in Sandwich public drinking water supplies (other
than TC) have been reported by the MDEP;
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· Several types of cancers diagnosed among children in Sandwich have been associated
with certain genetic diseases and familial disorders.  The MCR does not contain
information on an individual’s medical history.  Therefore, it is unknown if any children
diagnosed with cancer in Sandwich had any pre-existing medical conditions that might
increase their risk for certain types of cancer.
VII. RECOMMENDATIONS
Based on the observed geographic pattern of childhood cancer diagnoses in southeast Sandwich
during 1995 – 2005, the MDPH recommends the following steps:
· Conduct in-person interviews with the biological mother or primary care-givers of all
children diagnosed with cancer in Sandwich during 1995 – present.  Topics of interest
include closer scrutiny of pregnancy history, family medical history, and parental
occupational history.  Parents of children who provide informed consent will be asked to
participate in personal interviews and a medical records review by a physician to
determine any possible environmental or other factors that may have contributed to their
diagnosis;
· Review childhood cancer incidence in census tracts adjacent to Sandwich CT 0135.  This
would include CT 0131 in Barnstable and CT 0150 in Mashpee;
· Review additional environmental factors including but not limited to review of available
private well data.
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Appendix A
Coding Definitions of Childhood Cancer
ICD-O-3** codes
ICCC Diagnostic Group Morphology Topography
I. Leukemias, myeloproliferative diseases,
and myelodysplastic diseases
 a. Lymphoid leukemias 9820, 9823, 9826, 9827, 9831-9837, 9940,
9948
 b. Acute myeloid leukemias 9840, 9861, 9866, 9867, 9870-9874, 9891,
9895-9897, 9910, 9920, 9931
 c. Chronic myeloproliferative diseases 9863, 9875, 9876, 9950, 9960-9964
 d. Myelodysplastic syndrome and other
myeloproliferative diseases
9945, 9946, 9975, 9980, 9982-9987, 9989
 e. Unspecified and other specified
leukemias
9800, 9801, 9805, 9860, 9930
II.   Lymphomas and reticuloendothelial
neoplasms
 a. Hodgkin Lymphomas 9650-9655, 9659, 9661-9665, 9667
 b. Non-Hodgkin lymphomas (except
Burkitt lymphoma)
9591, 9670, 9671, 9673, 9675, 9678-9680,
9684, 9689-9691, 9695, 9698-9702, 9705,
9708, 9709, 9714, 9716-9719, 9727-9729,
9731-9734, 9760-9762, 9764-9769, 9970
 c. Burkitt lymphomas 9687
 d. Miscellaneous lymphoreticular
neoplasms
9740-9742, 9750, 9754-9758
 e. Unspecified lymphomas 9590, 9596
III. Central nervous system and miscellaneous
intracranial and intraspinal neoplasms
 a. Ependymomas and choroid plexus
tumors
9383, 9390-9394a
 b. Astrocytomas 9380a C72.3
9384, 9400-9411, 9420, 9421-9424, 9440-
9442a
 c. Intracranial and intraspinal embryonal
tumors
9470-9474, 9480, 9508a
9501-9504a C70.0-C72.9
 d. Other gliomas 9380a C70.0-C72.2, C72.4-C72.9,
C75.1, C75.3
9381, 9382, 9430, 9444, 9450, 9451, 9460a
 e. Other specified intracranial and
intraspinal neoplasms
8270-8281, 8300, 9350-9352, 9360-9362,
9412, 9413, 9492, 9493, 9505-9507, 9530-
9539, 9582a
* Chart from: Steliarova-Foucher E, Stiller C, Lacour B & Kaatsch P.  International classification of childhood cancer, third
edition. 2005. Cancer, 103, 1457-1467.
**International Classification of Diseases for Oncology, 3rd Ed.
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 f. Unspecified intracranial and Intraspinal
neoplasms 8000-8005a C70.0-C72.9, C75.1-C75.3
IV. Neuroblastoma and other peripheral
nervous cell tumors
 a. Neuroblastoma and
ganglioneuroblastoma
9490, 9500
 b. Other peripheral nervous cell tumors 8680-8683, 8690-8693, 8700, 9520-9523
9501-9504 C00.0-C69.9, C73.9-C76.8,
C80.9
V. Retinoblastoma 9510-9514
VI. Renal Tumors
 a. Nephroblastoma and other nonepithelial
renal tumors
8959, 8960, 8964-8967
8963, 9364 C64.9
 b. Renal carcinoma 8010-8041, 8050-8075, 8082, 8120-8122,
8130-8141, 8143, 8155, 8190-8201, 8210,
8211, 8221-8231, 8240, 8241, 8244-8246,
8260-8263, 8290, 8310, 8320, 8323, 8401,
8430, 8440, 8480-8490, 8504, 8510, 8550,
8560-8576
C64.9
8311, 8312, 8316-8319, 8361
 c. Unspecified malignant renal tumors 8000-8005 C64.9
VII. Hepatic Tumors
 a. Hepatoblastoma 8970
 b. Hepatic carcinoma 8010-8041, 8050-8075, 8082, 8120-8122,
8140, 8141, 8143, 8155, 8190-8201, 8210,
8211, 8230, 8231, 8240, 8241, 8244-8246,
8260-8264, 8310, 8320, 8323, 8401, 8430,
8440, 8480-8490, 8504, 8510, 8550, 8560-
8576
C22.0, C22.1
8160-8180
 c. Unspecified malignant hepatic tumors 8000-8005 C22.0, C22.1
VIII. Malignant bone tumors
 a. Osteosarcomas 9180-9187, 9191-9195, 9200 C40.0-C41.9, C76.0-C76.8,
C80.9
 b. Chondrosarcomas 9210, 9220, 9240 C40.0-41.9, 76.0-76.8, 80.9
9221, 9230, 9241-9243
 c. Ewing tumor and related sarcomas of
bone
9260 C40.0-C41.9, C76.0-76.8,
C80.9
9363-9365 C40.0-C41.9
 d. Other specified malignant bone tumors 8810, 8811, 8823, 8830 C40.0-C41.9
8812, 9250, 9261, 9270-9275, 9280-9282,
9290, 9300-9302, 9310-9312, 9320-9322,
9330, 9340-9342, 9370-9372
C40.0-C41.9
 e. Unspecified malignant bone tumors 8000-8005, 8800, 8801, 8803-8805 C40.0-C41.9
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IX.  Soft tissue and other extraosseous
sarcomas
a.    Rhabdomyosarcomas 8900-8905, 8910, 8912, 8920, 8991
b.    Fibrosarcomas, peripheral nerve sheath
tumors, and other fibrous neoplasms
8810, 8811, 8813-8815, 8821, 8823, 8834-
8835
C00.0-C39.9, C44.0-76.8,
C80.9
c.    Kaposi sarcoma 9140
d.   Other specified soft tissue sarcomas 8587, 8710-8713, 8806, 8831-8833, 8836,
8840-8842, 8850-8858, 8860-8862, 8870,
8880, 8881, 8890-8898, 8921, 8982, 8990,
9040-9044, 9120-9125, 9130-9133, 9135,
9136, 9141, 9142, 9161, 9170-9175, 9231,
9251, 9252, 9373, 9581
8830 C00.0-C39.9, C44.0-C76.8,
C80.9
8963 C00.0-C63.9, C65.9-C69.9,
C73.9-C76.8, C80.9
9180, 9210, 9220, 9240 C49.0-C49.9
9260 C00.0-C39.9, C47.0-C75.9
9364 C00.0-C39.9, C47.0-C63.9,
C65.9-C69.9, C73.9-C76.8,
C80.9
9365 C00.0-C39.9, C47.0-C63.9,
C65.9-C76.8, C80.9
       e.    Unspecified soft tissue sarcomas 8800-8805 C00.0-C39.9, C44.0-C76.8
X.   Germ cell tumors, trophoblastic tumors,
and neoplasms of gonads
a.    Intracranial and Intraspinal germ cell
tumors
9060-9065, 9070-9072, 9080-9085, 9100,
9101a
C70.0-C72.9, C75.1-C75.3
b.   Malignant extracranial and extragonadal
germ cell tumor
9060-9065, 9070-9072, 9080-9085, 9100-
9105
C00.0-C55.9, C57.0-C61.9,
C63.0-C69.9, C73.9-C75.0,
C75.4-C76.8, C80.9
       c.    Malignant gonadal germ cell tumors 9060-9065, 9070-9073, 9080-9085, 9090,
9091, 9100, 9101
C56.9, C62.0-C62.9
           d.   Gonadal carcinomas 8010-8041, 8050-8075, 8082, 8120-8122,
8130-8141, 8143, 8190-8201, 8210, 8211,
8221-8241, 8244-8246, 8260-8263, 8290,
8310, 8313, 8320, 8323, 8380-8384, 8430,
8440, 8480-8490, 8504, 8510, 8550, 8560-
8573, 9000, 9014, 9015
C56.9, C62.0-C62.9
8441-8447, 8450, 8451, 8460-8473
e. Other and unspecified malignant gonadal
tumors
8590-8671
8000-8005 C56.9, C62.0-C62.9
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XI. Other malignant epithelial neoplasms and
malignant melanomas
 a. Adrenocortical carcinomas 8370-8375
 b. Thyroid carcinomas 8010-8041, 8050-8075, 8082, 8120-8122,
8130-8141, 8190, 8200, 8201, 8211, 8230,
8231, 8244-8246, 8260-8263, 8290, 8310,
8320, 8323, 8430, 8440, 8480, 8481, 8510,
8560-8573
C73.9
8330-8337, 8340-8347, 8350
 c. Nasopharyngeal carcinomas 8010-8041, 8050-8075, 8082, 8083, 8120-
8122, 8130-8141, 8190, 8200, 8201, 8211,
8230, 8231, 8244-8246, 8260-8263, 8290,
8310, 8320, 8323, 8430, 8440, 8480, 8481,
8500-8576
C11.0-C11.9
 d. Malignant melanomas 8720-8780, 8790
 e. Skin carcinomas 8010-8041, 8050-8075, 8078, 8082, 8090-
8110, 8140, 8143, 8147, 8190, 8200, 8240,
8246, 8247, 8260, 8310, 8320, 8323, 8390-
8420, 8430, 8480, 8542, 8560, 8570-8573,
8940, 8941
C44.0-C44.9
 f. Other and unspecified carcinomas 8010-8084, 8120-8157, 8190-8264, 8290,
8310, 8313-8315, 8320-8325, 8360, 8380-
8384, 8430-8440, 8452-8454, 8480-8586,
8588-8589, 8940, 8941, 8983, 9000, 9010-
9016, 9020, 9030
C00.0-C10.9, C12.9-C21.8,
C23.9-C39.9, C48.0-C48.8,
C50.0-C55.9, C57.0-C61.9,
C63.0-C63.9, C65.9-C72.9,
C75.0-C76.8, C80.9
XII. Other and unspecified malignant
neoplasms
 a. Other specified malignant tumors 8930-8936, 8950, 8951, 8971-8981, 9050-
9055, 9110
9363 C00.0-C39.9, C47.0-C75.9
 b. Other unspecified malignant tumors 8000-8005 C00.0-C21.8, C23.9-C39.9,
C42.0-C55.9, C57.0-C61.9,
C63.0-C63.9, C65.9-C69.9,
C73.9-C75.0, C75.4-C80.9
ICD-0-3: International Classification of Diseases for Oncology, third edition; CNS: Central Nervous System
a Tumors with nonmalignant behavior are included for all morphology codes on the line.
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Explanation of a Standardized Incidence Ratio (SIR)
And 95% Confidence Interval
Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health
October, 2001
In order to evaluate cancer incidence a statistic known as a standardized incidence ratio (SIR) was
calculated for each cancer type.  An SIR is an estimate of the occurrence of cancer in a population
relative to what might be expected if the population had the same cancer experience as some larger
comparison population designated as “normal” or average.  Usually, the state as a whole is selected to be
the comparison population.  Using the state of Massachusetts as a comparison population provides a
stable population base for the calculation of incidence rates.  As a result of the instability of incidence
rates based on small numbers of cases, SIRs were not calculated when fewer than five cases were
observed.
Specifically, an SIR is the ratio of the observed number of cancer cases to the expected number of cases
multiplied by 100.  An SIR of 100 indicates that the number of cancer cases observed in the population
evaluated is equal to the number of cancer cases expected in the comparison or “normal” population.
An SIR greater than 100 indicates that more cancer cases occurred than expected and an SIR less than
100 indicates that fewer cancer cases occurred than expected.  Accordingly, an SIR of 150 is interpreted
as 50% more cases than the expected number; an SIR of 90 indicates 10% fewer cases than expected.
Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR depends
on both the size and the stability of the SIR.  Two SIRs can have the same size but not the same stability.
For example, an SIR of 150 based on 4 expected cases and 6 observed cases indicates a 50% excess in
cancer, but the excess is actually only two cases.  Conversely, an SIR of 150 based on 400 expected
cases and 600 observed cases represents the same 50% excess in cancer, but because the SIR is based
upon a greater number of cases, the estimate is more stable.  It is very unlikely that 200 excess cases of
cancer would occur by chance alone.
To determine if the observed number of cases is significantly different from the expected number or if
the difference may be due solely to chance, a 95% confidence interval (CI) was calculated for each SIR.
A 95% CI assesses the magnitude and stability of an SIR.  Specifically, a 95% CI is the range of
estimated SIR values that has a 95% probability of including the true SIR for the population.  If the 95%
CI range does not include the value 100, then the study population is significantly different from the
comparison or “normal” population.  “Significantly different” means there is less than 5% percent
chance that the observed difference is the result of random fluctuation in the number of observed cancer
cases.
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 105-130),
then there is statistically significant excess in the number of cancer cases.  Similarly, if the confidence
interval does not include 100 and the interval is below 100 (e.g., 45-96), then the number of cancer cases
is statistically significantly lower than expected.  If the confidence interval range includes 100, then the
true SIR may be 100, and it cannot be concluded with sufficient confidence that the observed number of
cases is not the result of chance and reflects a real cancer increase or decrease.  Statistical significance is
not assessed when fewer than five cases are observed.
In addition to the range of the estimates contained in the confidence interval, the width of the confidence
interval also reflects the stability of the SIR estimate.  For example, a narrow confidence interval (e.g.,
103--115) allows a fair level of certainty that the calculated SIR is close to the true SIR for the
population.  A wide interval (e.g., 85--450) leaves considerable doubt about the true SIR, which could
be much lower than or much higher than the calculated SIR.  This would indicate an unstable statistic.
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Risk Factor Information for Bone Cancer
Source: Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health
March, 2005
The occurrence of bone cancer is extremely rare; fewer than 2,600 primary cancers of the
bone and joints will be diagnosed in the U.S. in 2005, accounting for less than 0.2% of all
cancer types (ACS, 2005).  There are several different types of malignant or cancerous
bone tumors: osteosarcoma (about 35% of all cases), chondrosarcoma (26%), Ewing’s
sarcoma (or Ewing’s tumor) (16%), chordoma (8%), and malignant fibrous
histiocytoma/fibrosarcoma (6%).  Several rare types account for the remainder of cases
(ACS, 2000).  Osteosarcoma affects the bones themselves and primarily occurs in young
people between the ages of 10 and 30.  However, about 10% of cases develop in people
aged 60 to 80.  Chondrosarcoma is a cancer of the cartilage cells and is uncommon in
people under the age of 20.  After age 20, the risk of this disease increases with age.
Ewing’s sarcomas most often develop in the cavity of the bone and are usually diagnosed
in children and adolescents (ACS, 2000).  Among the major bone cancer types, males
experience a higher incidence of bone cancer than females.  Similar incidence rates for
osteosarcoma have been observed among whites and blacks.  However, in the United
States and Africa, the occurrence of Ewing’s sarcoma among black individuals is almost
non-existent.  The incidence of Ewing’s sarcoma among the Asian population is also very
low (Miller et al., 1996).
Very little is known about factors associated with the development of bone cancer.  In
fact, most people with bone cancer do not have any known risk factors (ACS, 2000).
Several pre-existing medical conditions are associated with the development of certain
primary bone cancers.  For example, osteosarcomas develop in about 5% to 10% of
severe cases of Paget’s disease, which primarily affects people over the age of 50 and
results in the formation of abnormal bone tissue (ACS, 2000).  The presence of multiple
exostoses (overgrowth of bone tissue) increases the risk of osteosarcoma, as does the
presence of multiple osteochondromas (benign tumors formed by bone and cartilage).  In
addition, an increased risk of chondrosarcoma has been observed among people with
multiple enchondromas (benign cartilage tumors), although this risk is very low (ACS,
2000).
Very few bone cancers appear to have a hereditary basis.  However, an elevated risk of
developing bone cancer (especially osteosarcoma) has been associated with a family
history of Li-Fraumeni syndrome.  In addition, children with an inherited form of
retinoblastoma, a rare eye cancer, have an increased risk for developing osteosarcoma
due to an abnormal mutation of the retinoblastoma gene (ACS, 2000).
Ionizing radiation has been identified as one of the only environmental factors known to
play a role in the development of certain types of bone cancer (e.g., osteosarcoma and
chondrosarcoma).  A typical x-ray of a bone does not pose a significant risk, but exposure
to high-dose radiation (e.g., radiation therapy to treat another type of cancer) and ongoing
exposure to internally deposited radionuclides (used to treat bone disease or for
diagnostic radiography) may increase the risk of bone cancer (ACS, 2000; Miller et al.,
1996).  Although the use of high dose radiation has been identified as a risk factor, it is
likely that less than 0.2% of patients treated develop bone cancer (Miller et al., 1996).
However, children with certain cancers seem to be particularly susceptible to radiogenic
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bone cancer and it appears that radiotherapy may interact with genetic susceptibility (e.g.,
due to a mutation in the retinoblastoma gene) (Miller et al., 1996).
Some studies have suggested that injury to a bone can cause cancer, but this has not been
corroborated and most doctors do not believe that trauma is a significant risk factor.  It is
more likely that a diagnosis prompts patients to remember an injury to a site or that an
injury draws their attention to a pre-existing bone mass (ACS, 2000).
Limited information is available regarding bone cancer and occupational risk factors
(Hoppin et al., 1999).  In the past, occupational exposure to radium was found to increase
the risk of developing bone cancer.  One study revealed that prior to 1930, women
employed as radium dial painters in the United States were found to be ingesting radium
orally by licking their paintbrushes to produce finer tips for finer lines.  Of the 1,474
women in the study, 4% developed bone cancer (Miller et al., 1996).  Some studies have
suggested that certain woodworking occupations (e.g. carpenters, furniture workers) are
associated with increased bone cancer mortality, but findings are inconsistent (Hoppin et
al., 1999).
Metal implants (e.g., hip replacement) are also thought to play a causal role in the
development of bone cancer.  This is thought to be due to the use of metals such as
chromium (a known human carcinogen) and nickel (a suspected human carcinogen), or
the use of bone cement.  While an association between bone cancer and metal implants is
suggested, no definitive links in humans have been identified (Miller et al., 1996).
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Brain and central nervous system (CNS) tumors can be either malignant (cancerous) or
benign (non-cancerous).  Primary brain tumors (i.e., brain cancer) comprise two main
types: gliomas and malignant meningiomas.  Gliomas are a general classification of
malignant tumors that include a variety of types, named for the cells from which they
arise: astrocytomas, oligodendrogliomas, and ependymomas.  Meningiomas arise from
the meninges, which are tissues that surround the outer part of the spinal cord and brain.
Although meningiomas are not technically brain tumors, as they occur outside of the
brain, they account for about 50% of all reported primary brain and spinal cord tumors.
The majority of meningiomas (about 85%) are benign and can be cured by surgery.
Therefore, approximately 7.5% of brain and CNS tumors are malignant meningiomas.  In
addition to these main types, there are a number of rare brain tumors, including
medulloblastomas, which develop from the primitive stem cells of the cerebellum and are
most often seen in children.  Also, the brain is a site where both primary and secondary
malignant tumors can arise; secondary brain tumors generally originate elsewhere in the
body and then metastasize, or spread, to the brain (ACS, 1999a).  The American Cancer
Society estimates that 18,500 Americans (10,620 men and 7,880 women) will be
diagnosed with primary brain cancer (including cancers of the central nervous system, or
spinal cord) and approximately 12,760 people (7,280 men and 5,480 women) will die
from this disease in 2005 (ACS, 2005).
Brain and spinal cord cancers account for over 20% of all cancer types diagnosed among
children aged 0-14 (ACS, 2005).  About half of all childhood brain tumors are
astrocytomas and 25% are medulloblastomas (ACS, 1999b).  After a peak in childhood
(generally under 10 years of age), the risk of brain cancer increases with age from age 25
to age 75.  In adults, the most frequent types of brain tumors are astrocytic tumors
(mainly astrocytomas and glioblastoma multiforme).  Incidence rates are higher in males
than in females for all types.  In general, the highest rates of brain and nervous system
cancer tend to occur in whites. However, this varies somewhat by type; the incidence of
gliomas is lower among black men and women than whites, but for meningiomas, the
reverse is true (Preston-Martin and Mack, 1996).
Despite numerous scientific and medical investigations, and analyses, the causes of brain
cancer are still largely unknown.  Among the possible risk factors investigated in relation
to this type of cancer are ionizing radiation, electromagnetic fields, occupational
exposures, exposure to N-nitroso compounds, head trauma, and genetic disorders.
The most established risk factor (and only established environmental risk factor) for brain
tumors (either cancerous or non-cancerous) is high-dose exposure to ionizing radiation
(i.e., x-rays and gamma rays).  Most radiation-induced brain tumors are caused by
radiation to the head from the treatment of other cancers (ACS, 1999a).  Meningiomas
are the most common type of tumors that occur from this type of exposure, but gliomas
may also occur (Preston-Martin and Mack, 1996).  Among adults, the risk of developing
meningiomas has been associated with full-mouth dental x-rays taken decades ago when
radiation doses were higher than today.  Although the relationship between low-dose
radiation exposure and increased risk of brain tumors has been debated in several studies,
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prenatal exposure from diagnostic x-rays has been related to an increase in childhood
brain tumors (Preston-Martin and Mack, 1996).
In recent years, there has been increasing public concern and scientific interest regarding
the relationship of electromagnetic fields (EMF) to brain cancer.  However, results from
recent epidemiological investigations provide little or no evidence of an association
between residential EMF exposure (e.g., from power lines and home appliances) and
brain tumors (Kheifets, 2001).  Studies also suggest that the use of handheld cellular
telephones is not associated with an increased risk of primary brain cancer (Muscat et al.,
2000).  However, given the relatively recent use of cellular phones, evidence is
preliminary and few studies have been conducted.
Other environmental factors such as exposure to vinyl chloride (used in the
manufacturing of some plastics) and aspartame (a sugar substitute) have been suggested
as possible risk factors for brain cancer but no conclusive evidence exists implicating
these factors (ACS, 1999a).  Although some occupational studies have suggested that
electrical and electric utility workers may be at a slightly increased risk of brain cancer,
these studies have important limitations, such as exposure misclassifications and a lack of
dose-response relationships (Kheifets, 2001).  Some researchers have also reported an
increased risk of brain tumors in adults among veterinarians and farmers.  Exposure to
farm animals and pets have been considered as possible risk factors because of their
association with bacteria, pesticides, solvents, and certain animal oncogenic (cancer-
related) viruses (Yeni-Komshian and Holly, 2000).  However, the relationship between
farm life and brain cancer remains controversial.
Recent reports have proposed a link between occupational exposure to lead and brain
cancer risk, but further analytic studies are warranted to test this hypothesis (Cocco et al.,
1998).  In a recent case-control study, the concentrations of metal and non-metal
compounds in brain biopsies from patients with primary brain tumors were compared to
results from an analysis of tumor-free brain tissue.  Statistically significant associations
were observed between the presence of brain tumors and the concentrations of silicon,
magnesium, and calcium (Hadfield et al., 1998).  However, further research using a larger
sample size is needed to determine whether exposure to these elements plays a role in the
development of brain cancer.  Other occupations that may be associated with elevated
risks include workers in certain health professions (e.g., pathologists and physicians),
agricultural workers, workers in the nuclear industry, and workers in the rubber industry,
although specific exposures have not been established (Preston-Martin and Mack, 1996).
Studies investigating the possible association between occupational exposure of parents
(in particular, paper or pulp-mill, aircraft, rubber, metal, construction, and electric
workers) and the onset of brain tumors in their children have provided inconsistent results
(Preston-Martin and Mack, 1996).
The association between the development of brain cancer and nitrites and other N-nitroso
compounds, among the most potent of carcinogens, has been heavily researched.  N-
nitroso compounds have been found in tobacco smoke, cosmetics, automobile interiors,
and cured meats.  A recent study concluded that an increased risk of pediatric brain tumor
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may be associated with high levels of nitrite intake from maternal cured meat
consumption during pregnancy (Pogoda and Preston-Martin, 2001).  However, the role of
nitrites and cured meats in the development of brain cancer remains controversial (Blot et
al., 1999; Bunin, 2000).  Because most people have continuous, low level exposure to N-
nitroso compounds throughout their lives, further studies, especially cohort studies, are
needed to determine if this exposure leads to an increased risk of brain tumors (Preston-
Martin, 1996).
Injury to the head has been suggested as a possible risk factor for later development of
brain tumors but most researchers agree that there is no conclusive evidence for an
association (ACS, 1999b).  Head trauma is most strongly associated with the
development of meningiomas compared with other types of brain tumor.  Several studies
have found an increased risk in women with histories of head trauma; in men who boxed;
and in men with a previous history of head injuries.  Gliomas are the most common type
of childhood brain tumor and have been positively associated with trauma at birth (e.g.,
Cesarean section, prolonged labor, and forceps delivery).  However, other studies have
found no association (Preston-Martin and Mack, 1996).
In addition, rare cases of brain and spinal cord cancer run in some families.  Brain tumors
in some persons are associated with genetic disorders such as neurofibromatosis types I
and II, Li-Fraumeni syndrome, and tuberous sclerosis.  Neurofibromatosis type I (von
Recklinghausen’s disease) is the most common inherited cause of brain or spinal cord
tumors and occurs in about one out of every 3,000 people (Preston-Martin and Mack,
1996).  The disease may be associated with optic gliomas or other gliomas of the brain or
spinal cord (ACS, 1999b).  Of those afflicted with the disease, about 5-10% will develop
a central nervous system tumor (Preston-Martin and Mack, 1996).  In addition, von
Hippell-Lindau disease is associated with an inherited tendency to develop blood vessel
tumors of the cerebellum (ACS, 1999a).  However, malignant (or cancerous) brain
tumors are rare in these disorders; inherited syndromes that predispose individuals to
brain tumors appear to be present in fewer than 5% of brain tumor patients (Preston-
Martin and Mack, 1996).
Other possible risk factors investigated for brain cancer have included alcohol
consumption, use of barbiturates, smoking and exposure to second-hand smoke,
pesticides, and infectious diseases (i.e., tuberculosis and chicken pox).  To date, studies
on these risk factors have yielded inconclusive results.  Further, the majority of
individuals diagnosed with brain cancer have no known risk factors (ACS, 1999a).
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Hodgkin’s disease (or Hodgkin’s lymphoma) is a form of cancer that involves the
lymphatic system and can be distinguished from non-Hodgkin’s lymphomas by cancer
cell type.  The American Cancer Society estimates that there will be approximately 7,350
new cases of this disease in the U.S. in 2005, accounting for less than 1% of all cancer
types, and approximately 1,410 deaths (ACS, 2005).  Because of substantial
improvement in effective therapy for this disease, mortality rates have decreased
approximately 60% since the early 1970s (ACS, 1999).
Epidemiologic studies have shown that Hodgkin’s disease is more common among men
than women and more common among whites than blacks.  People of Jewish descent
appear to be at higher risk of Hodgkin’s disease compared to people of non-Jewish
descent (Mueller, 1996).  Although the disease is relatively rare among children, two
peaks in the age distribution have been observed for this cancer type.  The first peak
occurs in young adults usually between the ages of 15 to 40 (typically ages 25-30) and
the second peak occurs in adults aged 55 years and above.
No major risk factors for Hodgkin’s disease have been found (ACS, 1999).  However, the
clinical and cellular features of Hodgkin’s disease suggest a chronic infectious process
(Mueller, 1996).  The bimodal age distribution of this disease suggests that two distinct
etiologies (or causes) for Hodgkin’s disease may be involved for each group.
Researchers have proposed that among young adults, Hodgkin’s disease is caused by a
biological agent of low infectivity.  Among individuals of older ages, the cause is
probably similar to those of other lymphomas (Mueller, 1996).  The virus that has been
linked most specifically to this disease is the Epstein-Barr virus (EBV).  EBV, a
herpesvirus, is common in the general population and causes mononucleosis or “mono.”
Approximately 40% to 50% of Hodgkin’s disease cases are associated with EBV (Weiss,
2000).  In addition, several studies have also shown that young adults who have
developed infectious mononucleosis have a significantly higher risk of developing
Hodgkin’s disease (ACS, 1999).  However, the absence of EBV infection in about half
the cases and the high prevalence of EBV in the general population suggest that EBV
may be only one of several factors in the development of this cancer.  Although
cytomegalovirus (CMV) and the more recently identified human herpesvirus type 6 have
been considered as possible factors in the development of Hodgkin’s disease, results of
antibody studies are inconsistent and these viruses do not appear to be related to risk of
Hodgkin’s disease (Mueller, 1996).
Slightly higher rates of Hodgkin’s disease occur among people with reduced immunity,
such as those with AIDS, people with congenital immune deficiencies, and individuals on
immunosuppressant medication following organ transplants.  However, Hodgkin’s
disease occurs at a much lower rate than non-Hodgkin’s lymphomas among this group of
individuals (ACS, 1999).
Hodgkin’s disease trends in the young adult population reveal that the disease has
become increasingly associated with populations both of middle to higher socioeconomic
status and small family size.  These factors are consistent with susceptibility to late
infections with common childhood viruses, supporting the theory that Hodgkin’s disease
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is associated with an infectious agent (Mueller, 1996).  Occupational exposures to
workers in the chemical industry and woodworkers have also been suggested in several
epidemiologic studies to be associated with the development of Hodgkin’s disease.
However, specific chemical exposures related to the development of this disease have not
been identified and results of studies investigating occupational exposures are
inconsistent (Mueller, 1996).  Based on an examination of medical and scientific
literature, the American Cancer Society concludes that although the exact cause remains
unknown, Hodgkin’s disease does not seem to be caused by genetic, lifestyle (e.g.,
dietary), or environmental factors (ACS, 1999).
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Leukemia is the general term that includes a group of different cancers that occur in the
blood forming organs and result in the formation of abnormal amounts and types of white
blood cells in the blood and bone marrow.  Individuals with leukemia generally maintain
abnormally high amounts of leukocytes or white blood cells in their blood.  This
condition results in an individual’s inability to maintain certain body functions,
particularly a person’s ability to combat infection.
In 2005, leukemia is expected to affect approximately 34,810 individuals (19,640 males
and 15,170 females) in the United States, resulting in 22,570 deaths.  In Massachusetts,
approximately 770 individuals will be diagnosed with the disease in 2005, representing
more than 2% of all cancer diagnoses.  There are four major types of leukemia: acute
lymphoid leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia
(CLL), and chronic myeloid leukemia (CML).  There are also a few rare types, such as
hairy cell leukemia.  In adults, the most common types are AML and CLL.  Leukemia is
the most common type of childhood cancer, accounting for about 30% of all cancers
diagnosed in children.  The majority of these cases are of the ALL type (ACS, 2005).
While ALL occurs predominantly among children (peaking between ages 2 and 3 years),
an elevation in incidence is also seen among older individuals.  The increase in incidence
among older individuals begins at approximately 40-50 years of age, peaking at about age
85 (Linet and Cartwright, 1996).  ALL is more common among whites than African
Americans and among males than females (Weinstein and Tarbell, 1997).  Exposure to
high-dose radiation (e.g., by survivors of atomic bomb blasts or nuclear reactor accidents)
is a known environmental risk factor associated with the development of ALL
(Scheinberg et al., 1997).  Significant radiation exposure (e.g., diagnostic x-rays) before
birth may carry up to a 5-fold increased risk of developing ALL (ACS, 2000b).
However, few studies report an increased risk of leukemia associated with residing in
proximity to nuclear plants or occupational exposure to low-dose radiation (Linet and
Cartwright, 1996; Scheinberg et al., 1997).  It is unclear whether exposure to
electromagnetic fields (EMF) plays a role in the development of ALL, however, most
studies to date have found little or no risk (ACS, 2000b).
Few other risk factors for ALL have been identified.  There is evidence that genetics may
play an important role in the development of this leukemia type.  Studies indicate that
siblings of twins who develop leukemia are at an increased risk of developing the disease.
Children with Down’s syndrome are 10 to 20 times more likely to develop acute
leukemia (Weinstein and Tarbell, 1997).  In addition, other genetic diseases, such as Li-
Fraumeni syndrome and Klinefelter’s syndrome, are associated with an increased risk of
developing leukemia.  Patients receiving medication that suppresses the immune system
(e.g., organ transplant patients) may be more likely to develop ALL (ACS 2000b).  ALL
has not been definitively linked to chemical exposure, however, childhood ALL may be
associated with maternal occupational exposure to pesticides during pregnancy (Infante-
Rivard et al., 1999).  Certain rare types of adult ALL are caused by human T-cell
leukemia/lymphoma virus-I (HTLV-I) (ACS, 2000a).  Some reports have linked other
viruses with various types of leukemia, including Epstein-Barr virus and hepatitis B
virus.  Still others propose that leukemia may develop as a response to viral infection.
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However, no specific virus has been identified as related to ALL (Linet and Cartwright,
1996).  Recent reports also suggest an infectious etiology for some childhood ALL cases,
although a specific viral agent has not been identified and findings from studies exploring
contact among children in day-care do not support this hypothesis (Greaves MF, 1997;
Kinlen and Balkwill, 2001; Rosenbaum et al., 2000).
Although AML can occur in children (usually during the first two years of life), AML is
the most common leukemia among adults, with an average age at diagnosis of 65 years
(ACS, 2000a and 2000b).  This type of leukemia is more common among males than
among females but affects African Americans and whites at similar rates (Scheinberg et
al., 1997).  High-dose radiation exposure (e.g., by survivors of atomic bomb blasts or
nuclear reactor accidents), long-term occupational exposure to benzene, and exposure to
certain chemotherapy drugs, especially alkylating agents (e.g., mechlorethamine,
cyclophosphamide), have been associated with an increased risk of developing AML
among both children and adults (ACS, 2000a and 2000b; Linet and Cartwright, 1996).
The development of childhood AML is suspected to be related to parental exposure to
pesticides and other chemicals, although findings are inconsistent (Linet and Cartwright,
1996).  Recent studies have suggested a link between electromagnetic field (EMF)
exposure (e.g., from power lines) and leukemia (Minder and Pfluger, 2001; Schuz et al.,
2001).  However, there is conflicting evidence regarding EMF exposure and leukemia
and it is clear that most cases are not related to EMF (ACS, 2000a; Kleinerman et al.,
2000).
Other possible risk factors related to the development of AML include cigarette smoking
and genetic disorders.  It is estimated that approximately one-fifth of cases of AML are
caused by smoking (Scheinberg et al., 1997).  Also, a small number of AML cases can be
attributed to rare inherited disorders.  These include Down’s syndrome in children,
Fanconi’s anemia, Wiskott-Aldrich syndrome, Bloom’s syndrome, Li-Fraumeni
syndrome, and ataxia telangiectasia (ACS, 2000a and 2000b).  Recently, scientists have
suggested that a mutation in a gene responsible for the deactivation of certain toxic
metabolites may have the ability to increase the risk of acute myeloid leukemia in adults.
However, further research is necessary in order to confirm the findings of this study
(Smith et al., 2001).
CLL is chiefly an adult disease; the average age at diagnosis is about 70 years (ACS,
1999).  Twice as many men as women are affected by this type of leukemia (Deisseroth
et al., 1997).  While genetics and diseases of the immune system have been suggested as
playing a role in the development of CLL, high-dose radiation and benzene exposure
have not (ACS, 1999; Weinstein and Tarbell, 1997).  It is thought that individuals with a
family history of CLL are two to four times as likely to develop the disease.  Some
studies have identified an increased risk of developing CLL (as well as ALL, AML, and
CML) among farmers due to long-term exposure to herbicides and/or pesticides (Linet
and Cartwright, 1996).  In addition, many researchers believe that cigarette smoking
plays a role in some chronic leukemias.  The role of EMF in the development of chronic
leukemia remains controversial (ACS, 1999).  Although viruses have been implicated in
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the etiology of other leukemias, there is no evidence that viruses cause CLL (Deisseroth
et al., 1997).
Of all the leukemias, CML is among the least understood.  While this disease can occur at
any age, CML is extremely rare in children (about 2% of leukemias in children) and the
average age of diagnosis is 40 to 50 years (ACS, 1999).  Incidence rates are higher in
males than in females, but unlike the other leukemia types, rates are higher in blacks than
in whites in the U.S. (Linet and Cartwright, 1996).  High-dose radiation exposure may
increase the risk of developing CML (ACS, 1999).  Finally, CML has been associated
with chromosome abnormalities such as the Philadelphia chromosome (Weinstein and
Tarbell, 1997).
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Appendix C
Risk Factor Information for Rhabdomyosarcoma
Source: American Cancer Society.  Located at www.cancer.org
What Are The Risk Factors for Rhabdomyosarcoma?
A risk factor is anything that increases your child’s chance of getting a disease such as
cancer. Different cancers have different risk factors. For example, exposing skin to strong
sunlight is a risk factor for skin cancer. Smoking is a risk factor for cancers of the lung,
mouth, larynx, bladder, kidney, and several other organs. But having a risk factor, or even
several, does not mean that your child will get the disease. Lifestyle-related risk factors
have little or no significance in childhood cancers.
Rhabdomyosarcoma is unlike most adult cancers in that there are no known
environmental conditions that increase your child’s chance of getting the disease. No
association has ever been documented between rhabdomyosarcoma and toxic substances,
air or water pollution, use of drugs or x-rays during pregnancy, or trauma (injury).
Inherited Conditions
There is evidence suggesting that people with certain conditions may inherit an increased
risk of developing rhabdomyosarcoma. Some families have an inherited tendency for
developing not only rhabdomyosarcoma, but also other tumors, including breast cancer
and brain tumors.
§ Members of families with Li-Fraumeni syndrome are more likely to develop
sarcomas, breast cancer, leukemia, and other cancers.
§ Children with Beckwith-Wiedemann syndrome have a high risk of developing
Wilms’ tumor, a type of kidney cancer, but children with this syndrome may also
develop rhabdomyosarcoma.
§ Neurofibromatosis, also known as von Recklinghausen disease, usually causes
multiple nerve tumors but also slightly increases the risk of rhabdomyosarcoma.
These inherited conditions are very rare and account for only a small fraction of
rhabdomyosarcoma cases, but they do suggest that the key to understanding
rhabdomyosarcoma will come from studying genes and how they work in very early life
to control cell growth and development.
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